1235544-51-0

Basic information

• Product Name: 2-(4-((ethoxycarbonothioyl)thio)phenyl)acetic acid
• Synonyms: 2-(4-((ethoxycarbonothioyl)thio)phenyl)acetic acid
• CAS NO: 1235544-51-0
• Molecular Weight: 256.346
• Mol File: 1235544-51-0.mol

Chemical Properties

• CAS DataBase Reference: 2-(4-((ethoxycarbonothioyl)thio)phenyl)acetic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(4-((ethoxycarbonothioyl)thio)phenyl)acetic acid(1235544-51-0)
• EPA Substance Registry System: 2-(4-((ethoxycarbonothioyl)thio)phenyl)acetic acid(1235544-51-0)

Safety Data

• Hazardous Substances Data: 1235544-51-0(Hazardous Substances Data)

Upstream product

• 1197-55-3 4-aminophenylacetic acid 
• 140-89-6 potassium ethyl xanthogenate 

Downstream Products

• 1391979-89-7 N-(4-(3-((dimethylamino)methyl)phenyl)-5-(2-(trifluoromethyl)phenoxy)thiazol-2-yl)-2-(4-(ethylsulfonyl)phenyl)acetamide trifluoroacetate 
• 1391979-87-5 N-(4-(3-chlorophenyl)-5-(4-methoxyphenoxy)thiazol-2-yl)-2-(4-(ethylsulfonyl)phenyl)acetamide 
• 1391979-86-4 N-(4-(3-chlorophenyl)-5-(2-isopropylphenoxy)thiazol-2-yl)-2-(4-(ethylsulfonyl)phenyl)acetamide 
• 1391979-85-3 N-(4-(3-chlorophenyl)-5-((2-chlorophenyl)(methyl)amino)thiazol-2-yl)-2-(4-(ethylsulfonyl)phenyl)acetamide 
• 1391979-84-2 N-{4-(4-chlorophenyl)-5-[methyl(phenyl)amino]-1,3-thiazol-2-yl}-2-[4-(ethylsulfonyl)phenyl]acetamide 
• 1391979-83-1 N-{4-(3-chlorophenyl)-5-[(2-chlorophenyl)methyl]-1,3-thiazol-2-yl}-2-[4-(ethylsulfonyl)phenyl]acetamide 
• 1391979-82-0 2-(4-(ethylsulfonyl)phenyl)-N-(4-phenyl-5-(1-phenylethyl)thiazol-2-yl)acetamide 
• 1391979-81-9 2-[4-(ethylsulfonyl)phenyl]-N-[4-phenyl-5-(phenylmethyl)-1,3-thiazol-2-yl]acetamide 
• 1391979-80-8 2-[4-(ethylsulfonyl)phenyl]-N-{5-[hydroxy(phenyl)methyl]-4-phenyl-1,3-thiazol-2-yl}acetamide 
• 1361413-25-3 N-{4-(2-chlorophenyl)-5-[(3-chlorophenyl)carbonyl]-1,3-thiazol-2-yl}-2-[4-(ethylsulfonyl)phenyl]acetamide 
• 1361413-24-2 N-{4-(2-chlorophenyl)-5-[(4-chlorophenyl)carbonyl]-1,3-thiazol-2-yl}-2-[4-(ethylsulfonyl)phenyl] acetamide 
• 1361413-23-1 N-{4-(4-chlorophenyl)-5-[(3-chlorophenyl)carbonyl]-1,3-thiazol-2-yl}-2-[4-(ethylsulfonyl)phenyl] acetamide 
• 1361413-22-0 N-{4-(4-chlorophenyl)-5-[(3-fluorophenyl)carbonyl]-1,3-thiazol-2-yl}-2-[4-(ethylsulfonyl)phenyl] acetamide 
• 1361413-21-9 N-{4-(4-chlorophenyl)-5-[(2-fluorophenyl)carbonyl]-1,3-thiazol-2-yl}-2-[4-(ethylsulfonyl)phenyl] acetamide 

Relevant articles and documents

SUBSTITUTED TETRAHYDROQUINOLINONE COMPOUNDS AS ROR GAMMA MODULATORS

The present invention provides substituted tetrahydroquinolinone and related compounds of formula (I), which are therapeutically useful as modulators of Retinoic acid receptor-related orphan receptors (RORs), more particularly as RORγ modulators. These co

FUSED PYRIDINE AND PYRIMIDINE DERIVATIVES AS ROR GAMMA MODULATORS

The present invention provides fused pyridine and pyrimidine derivatives of formula (I), which may be therapeutically useful, more particularly as RORγ modulators; in which Ra, Rb, A, B, X, P, Q, L, R4, R5 and m

FUSED THIOPHENE AND THIAZOLE DERIVATIVES AS ROR GAMMA MODULATORS

The present invention provides fused thiophene and thiazole derivatives of formula (I), which may be therapeutically useful, more particularly as RORγ modulators; in which R1, R2, R3, R4, R5, R6, R7, X1, X2, L, m, n and ring A have the meanings given in the specification, and pharmaceutically acceptable salts thereof that are useful in the treatment and prevention of diseases or disorders, in particular their use in disease(s) or disorder(s) where there is an advantage in modulating RORγ receptor. The present invention also provides preparation of the compounds and pharmaceutical formulations comprising at least one of the fused thiophene and thiazole derivatives of formula (I), together with a pharmaceutically acceptable carrier, diluent or excipient therefor.

DIHYDROPYRROLOPYRIDINE INHIBITORS OF ROR-GAMMA

Provided are novel compounds of Formula (I): pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful in the treatment of diseases and disorders mediated by RORy. Also provided are pharmaceutical compositions co

TRISUBSTITUTED HETEROCYCLIC DERIVATIVES AS ROR GAMMA MODULATORS

The present invention provides trisubstituted heterocyclic derivatives of formula (I), which may be therapeutically useful, more particularly as RORγ modulators; (I) in which R1, R2, R3, Ra, X, L, m and ring A have the meanings given in the specification, and pharmaceutically acceptable salts thereof that are useful in the treatment and prevention of diseases or disorder, in particular their use in diseases or disorder where there is an advantage in modulating RORγ receptor. The present invention also provides preparation of the compounds and pharmaceutical formulations comprising at least one of the trisubstituted heterocyclic derivatives of formula (I) together with a pharmaceutically acceptable carrier, diluent or excipient therefor.

THIAZALOPYRROLIDINE INHIBITORS OF ROR-GAMMA

Provided are novel compounds of Formula (I): pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful in the treatment of diseases and disorders mediated by ROR?. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I) and methods for their use in treating one or more inflammatory, metabolic, autoimmune and other diseases or disorders.

NOVEL COMPOUNDS

Novel retinoid-related orphan receptor gamma (ROR?) modulators and their use in the treatment of diseases mediated by ROR? provided by the present invention.

NOVEL COMPOUNDS

Disclosed are retinoid-related orphan receptor gamma (RORγ) modulators and their use in the treatment of diseases mediated by RORγ.

COMPOUNDS USEFUL AS RETINOID-RELATED ORPHAN RECEPTOR GAMMA MODULATORS

Disclosed are retinoid-related orphan receptor gamma (RORγ) modulators of Formula (I) and their use in the treatment of diseases mediated by RORγ, wherein the radicals have the meanings as defined in the invention.

RETINOID-RELATED ORPHAN RECEPTOR GAMMA MODULATORS, COMPOSITION CONTAINING THEM AND USES THEREOF

Provided are retinoid-related orphan receptor gamma(ROR γ) modulators of formula (I), processes for their preparation, pharmaceutical compositions containing them, and their uses in the treatment of diseases mediated by ROR γ.